CATALANO, ROSA
 Distribuzione geografica
Continente #
NA - Nord America 2.461
EU - Europa 2.007
AS - Asia 1.537
SA - Sud America 159
AF - Africa 70
OC - Oceania 8
Totale 6.242
Nazione #
US - Stati Uniti d'America 2.400
DE - Germania 891
CN - Cina 599
SG - Singapore 471
IT - Italia 392
GB - Regno Unito 180
HK - Hong Kong 158
SE - Svezia 140
BR - Brasile 126
IN - India 84
RU - Federazione Russa 69
NL - Olanda 67
VN - Vietnam 66
FR - Francia 61
CA - Canada 44
CI - Costa d'Avorio 40
FI - Finlandia 36
ID - Indonesia 32
JP - Giappone 30
DK - Danimarca 26
TR - Turchia 26
IE - Irlanda 25
ES - Italia 22
KR - Corea 17
AR - Argentina 16
RO - Romania 14
UA - Ucraina 14
MX - Messico 13
AT - Austria 12
PL - Polonia 11
BE - Belgio 10
BD - Bangladesh 9
CH - Svizzera 9
AU - Australia 6
EG - Egitto 6
ZA - Sudafrica 6
EC - Ecuador 5
NE - Niger 5
SC - Seychelles 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
BY - Bielorussia 4
CO - Colombia 4
IL - Israele 4
KG - Kirghizistan 4
PK - Pakistan 4
HR - Croazia 3
IR - Iran 3
LB - Libano 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
MM - Myanmar 1
NA - Namibia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 6.242
Città #
Dallas 1.168
Hanover 657
Ashburn 254
Singapore 218
Milan 157
Southend 150
Chandler 136
Hong Kong 133
Frankfurt am Main 96
Beijing 87
Hefei 81
San Jose 64
Los Angeles 52
Santa Clara 49
Munich 45
Ann Arbor 43
Abidjan 40
New York 37
Fairfield 36
Houston 36
Council Bluffs 35
Bengaluru 34
Princeton 26
Dublin 24
Redwood City 24
Ho Chi Minh City 23
Toronto 22
Woodbridge 22
Jakarta 21
Shanghai 21
Columbus 19
Dearborn 19
Guangzhou 19
Berlin 18
Buffalo 18
Helsinki 18
Wilmington 18
Tokyo 17
Istanbul 16
Seattle 16
Moscow 15
Padova 15
Cambridge 13
Cangzhou 13
Chicago 13
Fremont 13
Jinan 13
Seoul 13
São Paulo 13
Nanjing 12
Rome 12
Zhengzhou 12
Nuremberg 11
Des Moines 10
Montreal 9
Tianjin 9
Turku 9
Hangzhou 8
London 8
Mumbai 8
The Dalles 8
Turin 8
Cinisello Balsamo 7
Grafing 7
Hanoi 7
Brussels 6
Córdoba 6
Hebei 6
Lauterbourg 6
Ottawa 6
Phoenix 6
Pittsburgh 6
San Diego 6
Sevilla 6
Boardman 5
Farmington 5
Haiphong 5
Johannesburg 5
Lappeenranta 5
Nanchang 5
Niamey 5
Orem 5
Quanzhou 5
Rio de Janeiro 5
San Francisco 5
Shenyang 5
Valencia 5
Vienna 5
Bernolákovo 4
Boston 4
Brooklyn 4
Caserta 4
Denver 4
Düsseldorf 4
Espoo 4
Gustavo Adolfo Madero 4
Leipzig 4
Mahé 4
Minsk 4
Ningbo 4
Totale 4.407
Nome #
AZD1775: effect of monotherapy or EDP-M combination in the treatment of ACC preclinical models 424
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma 414
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells 391
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant 378
Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors 375
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors 354
The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells 354
A novel mechanism regulating dopamine receptor type 2 (DRD2) signal transduction in pituitary tumoral cells: the role of cAMP/PKA-induced filamin A (FLNA) phosphorylation 340
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion 322
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth 286
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 210
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 192
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation. 191
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells 183
Cytoskeleton protein Filamin A is required for efficient Somatostatin receptor type 2 internalization and recycling through Rab5 and Rab4 sorting endosomes in tumor somatotroph cells 182
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior 159
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling 150
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection 145
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells 133
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas 131
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs 130
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 112
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation 111
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 106
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas 96
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells 91
Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior 85
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells 82
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells 73
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs 72
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer 53
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma 47
The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets 15
Totale 6.387
Categoria #
all - tutte 16.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 21 32 38 37 36 23
2021/20221.070 19 35 53 124 151 139 135 104 132 62 25 91
2022/2023438 57 45 31 48 28 78 16 31 38 10 27 29
2023/2024451 22 23 15 33 131 13 51 39 16 29 32 47
2024/20251.084 31 61 25 97 99 53 34 103 59 150 138 234
2025/20262.655 305 1.281 336 266 222 134 111 0 0 0 0 0
Totale 6.387